Systemic MastocytosisSymptoms, Doctors, Treatments, Advances & More
Systemic Mastocytosis Overview
Learn About Systemic Mastocytosis
Systemic mastocytosis is a blood disorder that can affect many different body systems. Individuals with the condition can develop signs and symptoms at any age, but it usually appears after adolescence.
Systemic mastocytosis occurs when white blood cells called mast cells, which are produced in bone marrow, abnormally accumulate in one or more tissues. In most cases of systemic mastocytosis, the accumulated mast cells have a mutation in a gene called KIT. The KIT gene provides instructions for making a protein that plays an important role in development and activity of mast cells. The KIT protein stimulates chemical signaling pathways that are involved in the growth and division (proliferation) of many types of cells, including mast cells. In systemic mastocytosis, KIT gene mutations are somatic, which means they are acquired during a person's lifetime. These mutations result in a KIT protein that is always turned on (activated). As a result, signaling pathways are overactive, leading to increased production and accumulation of mast cells.
Systemic mastocytosis is estimated to occur in 1 per 10,000 to 20,000 individuals worldwide.
This condition is generally not inherited but arises from a somatic mutation in the body's cells that occurs after conception.
Domino's Farms
Cem Akin is a primary care provider, practicing in Internal Medicine in Ann Arbor, Michigan. Dr. Akin is rated as an Elite provider by MediFind in the treatment of Systemic Mastocytosis. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Anaphylaxis, Urticaria Pigmentosa, and Tissue Biopsy. Dr. Akin is currently accepting new patients.
Duke Cancer Center
Carlos De Castro Iii is a Hematologist Oncology specialist and a Hematologist practicing medicine in Durham, North Carolina. Dr. De Castro Iii is rated as a Distinguished provider by MediFind in the treatment of Systemic Mastocytosis. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. De Castro Iii is board certified in American Board Of Internal Med, Internal Medicine. Dr. De Castro Iii is currently accepting new patients.
Stanford University
Jason Gotlib is a Hematologist practicing medicine in Palo Alto, California. Dr. Gotlib is rated as an Elite provider by MediFind in the treatment of Systemic Mastocytosis. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Myelofibrosis, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Gotlib is currently accepting new patients.
Summary: This is a Phase 4, non-interventional, observational study to collect detailed data on the clinical characteristics, clinical outcomes and medical management of ISM in real-world settings. The study will describe the demographic and clinical characteristics of ISM participants, including anaphylaxis and bone manifestations in ISM. Quality of life and disease control will be assessed through partic...
Summary: This clinical trial aims to evaluate and compare novel and commercially available diagnostic assays through blood tests for the differential diagnosis and comprehensive assessment of patients experiencing recurrent angioedema attacks, including both urticarial and non-urticarial angioedema. The primary objective is to assess the efficiency of novel diagnostic assays, both individually and in combi...
Published Date: October 01, 2018
Published By: National Institutes of Health

